MoST
09 Dec 2020
MoST
ACTRN12616000908437
The Cancer Molecular Screening and Therapeutics (MoST) Program – A framework protocol for multiple, parallel, signal-seeking clinical studies of novel molecularly targeted therapies for patients with advanced cancer and unmet clinical need.
The University of Sydney
Cancer Type | All cancers |
---|---|
Trial Type | Early detection, diagnosis, prognosis |
Phase | All phases |
Age Range | 18 years and older |
Sex | All |
Tumour Stream | - |
Cancer Stage | Locally Recurrent or Locally Advanced; Metastatic or Widespread |
Anticipated Start Date | 2016-09-09 |
Anticipated End Date | 2020-09-11 |
Hospital | Royal Adelaide Hospital |
---|---|
Clinical Trial Coordinator | Anne Milton |
anne.milton@sa.gov.au | |
Phone | 08 7074 2342 |
Principal Investigator | Professor Michael Brown |
Recruitment Status | Recruiting |
Hospital | Flinders Medical Centre |
---|---|
Clinical Trial Coordinator | Alison Richards |
Alison.Richards@sa.gov.au | |
Phone | 08 8206 4835 |
Principal Investigator | Dr Chris Karapetis |
Recruitment Status | Recruiting |
Keep up to date with the latest news and breakthroughs